Report cover image

Medical Aesthetics Market Share, Size, Trends, Industry Analysis Report, By Product; By End-Use (Clinics, Hospitals and Medical Spas, Beauty Centers, Home Care Settings); By Region; Segment Forecast, 2022 - 2030

Published Sep 01, 2025
Length 114 Pages
SKU # PLRS20470336

Description

The global medical aesthetics market size is expected to reach USD 55.09 billion by 2034 according to a new study by Polaris Market Research. The report “Medical Aesthetics Market Share, Size, Trends, Industry Analysis Report, By Product; By End-Use (Clinics, Hospitals and Medical Spas, Beauty Centers, Home Care Settings); By Region; Segment Forecast, 2025 - 2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The growing implementation of minimally invasive and non-invasive aesthetic procedures and the increasing acceptance of aesthetic procedures among elderly individuals are the factors stimulating the market’s growth. Additionally, the accessibility of advanced and user-friendly products along with growing demand for aesthetic treatments among men are supposed to positively influence the industry growth.

The rising need to appear younger and visible positive effects are accelerating the market's growth. Furthermore, the development of home-use aesthetic devices is supposed to create lucrative opportunities for the market players.

Due to decreased product demand, constrained operations, and temporary closures of beauty salons, COVID-19 overall affected the medical aesthetics market. Additionally, the market has seen a reduction in aesthetic procedures due to the Covid-19 pandemic, which has affected the market growth.

Medical Aesthetics Market Report Highlights

The facial medical aesthetics segment accounted for the most considerable market revenue in 2024 due to the rising popularity of modifying facial characteristics, less expensive alternatives to invasive beauty procedures, and the accessibility of high-tech face aesthetic products.

The clinics, hospitals, and medical spaces segment accounted for the most significant market share due to the rising demand for minimally invasive aesthetic procedures and the introduction of medical spas and clinics with infrastructure fully loaded with state-of-the-art equipment and people.

North America dominated the regional market due to the growing acceptance of aesthetic surgery and high procedural volume sustained in emerging economies such as the US and Canada.

The global market is highly competitive owning to the existence of large industry players with the global presence including 3M, ADIN Dental Implant Systems, Allergan plc, Anika Therapeutics, Inc., Cynosure Inc., Deka Laser Technologies, Dentsply Sirona Inc., El.En. S.p.A., Etoile, Fotona D.O.O., Galderma S.A, GymnaUniphy N.V., Medytox, INC, Mentor Worldwide LLC, Merz Aesthetics, Inc., NDI Dental Implants, PhotoMedex, Inc., Sientra, Inc., Sinclair Pharma PLC, Solta Medical, Solta Medical, Inc., Syneron Medical, Ltd., Tecno Gamma, TRI Dental Implants, YOLO Medical, ZELTIQ Aesthetics, Inc., and Zimmer Biomet Holdings, Inc.

Polaris Market Research has segmented the medical aesthetics market report based on product, end-use, and region:

Medical Aesthetics, Product Outlook (Revenue - USD Billion, 2020 - 2034)

Facial Aesthetic Products

Botulinum toxin

Derma Filers

Microdermabrasion Products

Chemical Peels

Cosmetic Implants

Breast Implants

Gluteal Implants

Facial Implants

Skin Aesthetic Devices

Nonsurgical Skin Tightening Devices

Laser Skin Resurfacing Devices

Micro needling products

Light Therapy Devices

Body Contouring Devices

Nonsurgical Fat Reduction Devices

Cellulite Reduction Devices

Liposuction Devices

Physician-Dispensed Cosmeceuticals & Skin Lighteners

Hair Removal Devices

Laser Hair Removal Devices

IPL hair Removal Devices

Tattoo Removal Devices

Thread Lift Products

Physician-Dispensed Eyelash Products

Nail Treatment Laser Devices

Medical Aesthetics, End-Use Outlook (Revenue - USD Billion, 2020 - 2034)

Clinics, Hospitals and Medical Spas

Beauty Centers

Home Care Settings

Medical Aesthetics, Regional Outlook (Revenue - USD Billion, 2020 - 2034)

North America

U.S

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

114 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Japan Dietary Supplements Market Insights
4.1. Dietary Supplements Market – Application Snapshot
4.2. Dietary Supplements Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Ageing Population
4.2.1.2. Trust in Functional Foods and Science-Based Products
4.2.2. Restraints and Challenges
4.2.2.1. High Cost of Products
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Dietary Supplements Market Application Trends
4.6. Value Chain Analysis
5. Japan Dietary Supplements Market, by Type
5.1. Key Findings
5.2. Introduction
5.2.1. Japan Dietary Supplements Market, by Type, 2020-2034 (USD Billion)
5.3. Vitamins
5.3.1. Japan Dietary Supplements Market, by Vitamins, 2020-2034 (USD Billion)
5.4. Minerals
5.4.1. Japan Dietary Supplements Market, by Minerals, 2020-2034 (USD Billion)
5.5. Amino Acids
5.5.1. Japan Dietary Supplements Market, by Amino Acids 2020-2034 (USD Billion)
5.6. Botanicals
5.6.1. Japan Dietary Supplements Market, by Botanicals, 2020-2034 (USD Billion)
5.7. Probiotics
5.7.1. Japan Dietary Supplements Market, by Probiotics, 2020-2034 (USD Billion)
5.8. Enzymes
5.8.1. Japan Dietary Supplements Market, by Enzymes, 2020-2034 (USD Billion)
5.9. Others
5.9.1. Japan Dietary Supplements Market, by Others, 2020-2034 (USD Billion)
6. Japan Dietary Supplements Market, by Form
6.1. Key Findings
6.2. Introduction
6.2.1. Japan Dietary Supplements Market, by Form, 2020-2034 (USD Billion)
6.3. Tablets
6.3.1. Japan Dietary Supplements Market, by Tablets, 2020-2034 (USD Billion)
6.4. Capsules
6.4.1. Japan Dietary Supplements Market, by Capsules, 2020-2034 (USD Billion)
6.5. Gummies
6.5.1. Japan Dietary Supplements Market, by Gummies, 2020-2034 (USD Billion)
6.6. Powder
6.6.1. Japan Dietary Supplements Market, by Powder, 2020-2034 (USD Billion)
6.7. Soft Gels
6.7.1. Japan Dietary Supplements Market, by Soft Gels, 2020-2034 (USD Billion)
6.8. Liquids
6.8.1. Japan Dietary Supplements Market, by Liquids, 2020-2034 (USD Billion)
6.9. Others
6.9.1. Japan Dietary Supplements Market, by Others 2020-2034 (USD Billion)
7. Japan Dietary Supplements Market, by Application
7.1. Key Findings
7.2. Introduction
7.2.1. Japan Dietary Supplements Market, by Application, 2020-2034 (USD Billion)
7.3. Energy & Weight Management
7.3.1. Japan Dietary Supplements Market, by Energy & Weight Management, 2020-2034 (USD Billion)
7.4. Bone & Joint Health
7.4.1. Japan Dietary Supplements Market, by Bone & Joint Health, 2020-2034 (USD Billion)
7.5. Immunity
7.5.1. Japan Dietary Supplements Market, by Immunity, 2020-2034 (USD Billion)
7.6. General Health
7.6.1. Japan Dietary Supplements Market, by General Health, 2020-2034 (USD Billion)
7.7. Cardia Health
7.7.1. Japan Dietary Supplements Market, by Cardia Health 2020-2034 (USD Billion)
7.8. Others
7.8.1. Japan Dietary Supplements Market, by Others, 2020-2034 (USD Billion)
8. Japan Dietary Supplements Market, by Distribution Channel
8.1. Key Findings
8.2. Introduction
8.2.1. Japan Dietary Supplements Market, by Distribution Channel, 2020-2034 (USD Billion)
8.3. Online Platforms
8.3.1. Japan Dietary Supplements Market, by Online Platforms, 2020-2034 (USD Billion)
8.4. Offline Stores
8.4.1. Japan Dietary Supplements Market, by Offline Stores, 2020-2034 (USD Billion)
9. Japan Dietary Supplements Market, by End Use
9.1. Key Findings
9.2. Introduction
9.2.1. Japan Dietary Supplements Market, by End Use, 2020-2034 (USD Billion)
9.3. Adults
9.3.1. Japan Dietary Supplements Market, by Adults, 2020-2034 (USD Billion)
9.4. Children
9.4.1. Japan Dietary Supplements Market, by Children, 2020-2034 (USD Billion)
9.5. Infants
9.5.1. Japan Dietary Supplements Market, by Infants, 2020-2034 (USD Billion)
9.6. Pregnant Women
9.6.1. Japan Dietary Supplements Market, by Pregnant Women, 2020-2034 (USD Billion)
9.7. Geriatric
9.7.1. Japan Dietary Supplements Market, by Geriatric, 2020-2034 (USD Billion)
10. Competitive Landscape
10.1. Expansion and Acquisition Analysis
10.1.1. Expansion
10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
11.1. Abbott Laboratories
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Recent Development
11.2. Glanbia Plc
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Benchmarking
11.2.4. Recent Development
11.3. The Archer-Daniels-Midland Company
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Benchmarking
11.3.4. Recent Development
11.4. Nature’s Sunshine Products, Inc.
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Benchmarking
11.4.4. Recent Development
11.5. GlaxoSmithKline plc
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Benchmarking
11.5.4. Recent Development
11.6. Amway Corp.
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Benchmarking
11.6.4. Recent Development
11.7. Herbalife International of America, Inc.
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Benchmarking
11.7.4. Recent Development
11.8. PharmaNutrics Himalaya Japan Holdings Ltd.
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Benchmarking
11.8.4. Recent Development
11.9. dsm-firmenich
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Benchmarking
11.9.4. Recent Development
11.10. Pfizer Inc.
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Benchmarking
11.10.4. Recent Development
11.11. Bayer AG
11.11.1. Company Overview
11.11.2. Financial Performance
11.11.3. Product Benchmarking
11.11.4. Recent Development
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.